Differential diagnosis of cerebral infarction using an algorithm combining atrial fibrillation and D-dimer level

European Journal of Neurology

Volumn 15, Issue 3, 2008, Pages 295-300

  Dougu, N ^a   Takashima, S ^a   Sasahara, E ^a   Taguchi, Y ^a   Toyoda, S ^a   Hirai, T ^a   Nozawa, T ^a   Tanaka, K ^a   Inoue, H ^a  

^a TOYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Atrial fibrillation; Cardioembolic infarction; Cerebral infarction; D dimer; Diagnosistic algorithm; Early diagnosis; Hemostatic marker; Stroke subtypes; TOAST criteria

Indexed keywords

D DIMER;

AGED; ALGORITHM; ARTICLE; BRAIN INFARCTION; DIFFERENTIAL DIAGNOSIS; EMBOLISM; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

AGED; AGED, 80 AND OVER; ALGORITHMS; ATRIAL FIBRILLATION; CEREBRAL INFARCTION; DIAGNOSIS, DIFFERENTIAL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 39149091050     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02063.x     Document Type: Article

References (22)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine 1995 333 : 1581 1587.
2. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The european cooperative acute stroke study (ECASS). JAMA 1995 274 : 1017 1025.
3. Yamaguchi T, Mori E, Minematsu K, et al. Alteplase at 0.6mg/kg for acute ischemic stroke within 3 h of oncet. Japan alteplase clinical trial (J-ACT). Stroke 2006 37 : 1810 1815.
4. von Kummar R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997 205 : 327 333.
5. Madden KP, Karanjia PN, Adams HP, Clarke WR. Accuracy of initial stroke subtype diagnosis in the TOAST study. Neurology 1995 45 : 1975 1979.
6. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001 32 : 2735 2740.
7. Boisclair MD, Ireland H, Lane DA. Assesment of hypercoagulable states by measurement of activation fragments and peptides. Blood Reviews 1990 4 : 25 40.
8. Takano K, Yamaguchi T, Uchida K. Markers of a hypercoagulable state following acute ischemic stroke. Stroke 1992 23 : 194 198.
9. Feinberg WM, Erickson LP, Bruck D, Kittelson J. Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome. Stroke 1996 27 : 1296 1300.
10. Ageno W, Finazzi S, Steidl L, et al. Plasma measurement of d-dimer levels for the early diagnosis of ischemic stroke subtypes. Archives of Internal Medicine 2002 162 : 2589 2593.
11. Fisher M, Francis R. Altered coagulation in cerebral ischema: platelet, thrombin, and plasmin activity. Archives Neurology 1990 47 : 1075 1079.
12. Tohgi H, Kawashima M, Tamura K, Suzuki H. Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism. Stroke 1990 21 : 1663 1667.
13. Koch HJ, Horn M, Bogdahn U, Ickenstein GW. The relationship between plasma d-dimer concentrations and acute ischemic stroke subtypes. Journal of Stroke and Cerebrovascular Diseases 2005 14 : 75 79.
14. Inoue H, Nozawa T, Okumura K, Lee JD, Shimizu A, Yano K. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism. Chest 2004 126 : 687 692.
15. Nozawa T, Inoue H, Hirai M, et al. D-dimer level influences thromboembolic events in patients with atrial fibrillation. International Journal of Cardiology 2006 109 : 59 65.
16. Kario K, Matsuo T, Kabayashi H, et al. Rapid quantitative evaluation of plasma d-dimer levels in thrombotic states using an automated latex photometric immunoassay. Thrombosis Research 1992 66 : 179 189.
17. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993 24 : 35 41.
18. Hart RG, Pearce LA, Miller VT, et al. Cardioembolic vs. Noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovascular Diseases 2000 10 : 39 43.
19. Barber M, Langhorne P, Rumley A, Lowe GDO, Stott DJ. Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke 2004 35 : 1421 1425.
20. Ono N, Koyama T, Suehiro A, Oku K, Fujikake K, Kakishita E. Clinical significance of new coagulation and fibrinolytic markers in ischemic stroke patients. Stroke 1993 33 : 1369 1373.
21. Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism. Annals of Internal Medicine 2004 140 : 589 602.
22. Wolde MT, Kraaijenhagen RA, Prins MH, Büller HR. The clinical usefulness of d-dimer testing in cancer patients with suspected deep vein thrombosis. Archives of Internal Medicine 2002 162 : 1880 1884.